REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 171 filers reported holding REVOLUTION MEDICINES INC in Q3 2023. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $161,707 | +9.1% | 5,842 | +5.5% | 0.01% | +14.3% |
| Q2 2023 | $148,195 | +47.1% | 5,540 | +19.1% | 0.01% | +40.0% |
| Q1 2023 | $100,719 | -9.3% | 4,650 | -0.2% | 0.01% | 0.0% |
| Q4 2022 | $111,025 | +25.6% | 4,661 | +4.0% | 0.01% | +25.0% |
| Q3 2022 | $88,365 | +16.1% | 4,481 | +14.8% | 0.00% | +33.3% |
| Q2 2022 | $76,108 | -23.6% | 3,905 | 0.0% | 0.00% | -25.0% |
| Q1 2022 | $99,617 | -76.1% | 3,905 | -76.4% | 0.00% | -33.3% |
| Q4 2021 | $416,513 | -8.5% | 16,548 | 0.0% | 0.01% | -14.3% |
| Q3 2021 | $455,235 | -13.3% | 16,548 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $525,234 | +3.1% | 16,548 | +49.0% | 0.01% | -12.5% |
| Q1 2021 | $509,681 | +12.6% | 11,109 | -2.9% | 0.01% | +14.3% |
| Q4 2020 | $452,751 | +13.8% | 11,436 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $397,973 | +154.2% | 11,436 | +130.6% | 0.01% | +133.3% |
| Q2 2020 | $156,556 | +44.1% | 4,959 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $108,652 | – | 4,959 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $133,958,163 | 40.59% |
| Column Group LLC | 1,230,641 | $34,064,143 | 22.62% |
| Boxer Capital, LLC | 4,684,264 | $129,660,428 | 6.90% |
| Finepoint Capital LP | 427,000 | $11,819,360 | 5.89% |
| Casdin Capital, LLC | 1,810,000 | $50,100,800 | 5.54% |
| EcoR1 Capital, LLC | 5,577,863 | $154,395,248 | 5.21% |
| DAFNA Capital Management LLC | 473,394 | $13,103,546 | 4.08% |
| Artal Group S.A. | 2,529,737 | $70,023 | 3.00% |
| BVF INC/IL | 3,981,212 | $110,199,948 | 2.97% |
| Bellevue Group AG | 4,721,500 | $130,691,120 | 2.11% |